Aiforia Technologies Oyj

AIFORIA · Nasdaq Helsinki · Healthcare

0.96EUR −1.6%last day

Price as of 2 October 2026

The price over the past year, with dividends: −64.6%

Performance

1 month

−2.1%

1 year

−64.6%

3 years, per year

−36.8%

5 years, per year

–

Largest fall, 3 years

−82.0%

Below the peak now

−82.6%

Volatility, 1 year

56.5%

Return with dividends reinvested.

Key figures

P/E

negative earnings

P/B

2.1

Dividend yield

0.0%

Return on equity

−76.2%

Net margin

–

Market value

40 m USD

Quality, value and trend

Where Aiforia Technologies stands against every Nordic stock today. 100 is best.

Quality34

Profitability and a sound balance sheet over time. Better than 34% of Nordic stocks.

Value7

The price measured against earnings, assets and cash flow. Better than 7% of Nordic stocks.

Trend3

The price development over the past year. Better than 3% of Nordic stocks.

Combined2

Quality, value and trend together. Better than 2% of Nordic stocks.

About Aiforia Technologies

Aiforia Technologies Oyj is a company in healthcare, listed on Nasdaq Helsinki. The share trades in EUR. It has around 67 employees.

Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools for the treatment of various cancers, such as breast, lung, and prostate cancer; CE-IVD marked Aiforia clinical suite viewer for the clinical pathology workflow; and Aiforia Create, an agile solution to develop an AI model for image analysis application.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis